摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2,2-diphenylvinyl)-1H-indole

中文名称
——
中文别名
——
英文名称
3-(2,2-diphenylvinyl)-1H-indole
英文别名
ZINC03149578;3-(2,2-diphenylethenyl)-1H-indole
3-(2,2-diphenylvinyl)-1H-indole化学式
CAS
——
化学式
C22H17N
mdl
——
分子量
295.384
InChiKey
RHKQWJSSRSYEGH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    15.8
  • 氢给体数:
    1
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    3-(2,2-diphenylvinyl)-1H-indole 在 manganese(III) triacetate dihydrate 、 溶剂黄146 作用下, 反应 0.05h, 以26%的产率得到2-(1H-indol-3-yl)-1,2-diphenylethan-1-one
    参考文献:
    名称:
    Facile Synthesis of Indolelactones Using Mn(III)-Based Oxidative Substitution-Cyclization Reaction
    摘要:
    Based on the oxidation of indole with Mn(OAc)(3) in the presence of 1,1-diarylethenes affording 3-vinyl-substituted indoles, a similar oxidation using indole-2-carboxylic acids was evaluated in order to effectively introduce the substituent group to the C-3 position of the indolecarboxylic acids. The coupling reaction followed by oxidative cyclization smoothly proceeded at room temperature in an AcOH-HCO2H mixed solvent to give the desired indolelactones in high yields. The reaction details, the structure determination of the products and a brief reaction mechanism are described.
    DOI:
    10.3987/com-18-s(t)31
  • 作为产物:
    描述:
    1,1-二苯基乙醇硫酸 、 manganese(III) triacetate dihydrate 、 溶剂黄146 作用下, 以 为溶剂, 反应 0.17h, 生成 3-(2,2-diphenylvinyl)-1H-indole
    参考文献:
    名称:
    Facile Synthesis of Indolelactones Using Mn(III)-Based Oxidative Substitution-Cyclization Reaction
    摘要:
    Based on the oxidation of indole with Mn(OAc)(3) in the presence of 1,1-diarylethenes affording 3-vinyl-substituted indoles, a similar oxidation using indole-2-carboxylic acids was evaluated in order to effectively introduce the substituent group to the C-3 position of the indolecarboxylic acids. The coupling reaction followed by oxidative cyclization smoothly proceeded at room temperature in an AcOH-HCO2H mixed solvent to give the desired indolelactones in high yields. The reaction details, the structure determination of the products and a brief reaction mechanism are described.
    DOI:
    10.3987/com-18-s(t)31
点击查看最新优质反应信息

文献信息

  • [EN] BINDING FUNCTION3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE<br/>[FR] COMPOSÉS DE SITE DE (BF3) AYANT UNE FONCTION 3 DE LIAISON UTILISÉS EN TANT QU'AGENTS THÉRAPEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
    申请人:UNIV BRITISH COLUMBIA
    公开号:WO2015154169A1
    公开(公告)日:2015-10-15
    This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    这项发明提供了具有以下结构的化合物:这些化合物的用途包括治疗各种症状,包括前列腺癌,还提供了涉及这些化合物的治疗方法。
  • Cobalt-catalysed reductive C–H alkylation of indoles using carboxylic acids and molecular hydrogen
    作者:Jose R. Cabrero-Antonino、Rosa Adam、Kathrin Junge、Matthias Beller
    DOI:10.1039/c7sc02117h
    日期:——
    further demonstrated through the C3 alkylation of several substituted indole derivatives using acetic, phenylacetic or diphenylacetic acids. In addition, a careful selection of the reaction conditions allowed to perform the selective C3 alkenylation of some indole derivatives. Moreover, the alkenylation of C2 position of 3-methyl-1H-indole was also possible. Control experiments indicate that the aldehyde
    首次提出了使用羧酸对吲哚进行直接CH-烷基化反应。在Al(OTf)3作为助催化剂的情况下,基于Co(acac)3和1,1,1-三(二苯基膦基甲基)-乙烷(Triphos,L1)的组合的催化体系2-甲基-1 H-吲哚与各种羧酸的还原烷基化反应 通过使用乙酸,苯乙酸或二苯乙酸将几种取代的吲哚衍生物进行C3烷基化,进一步证明了该协议的实用性。另外,仔细选择反应条件可以进行一些吲哚衍生物的选择性C 3烯基化。另外,3-甲基-1 H的C2位的烯基化-吲哚也是可能的。对照实验表明,由羧酸加氢就地形成的醛在整个过程中起着核心作用。该新方案可使用基于非贵金属的催化剂和氢作为还原剂,将吲哚直接与易于获得的稳定羧酸官能化。
  • Binding function 3 (BF3) site compounds as therapeutics and methods for their use
    申请人:THE UNIVERSITY OF BRITISH COLUMBIA
    公开号:US10351527B2
    公开(公告)日:2019-07-16
    This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    本发明提供了具有式结构的化合物:本发明还提供了此类化合物在治疗包括前列腺癌在内的各种适应症方面的用途,以及涉及此类化合物的治疗方法。
  • Binding Function 3 (BF3) site compounds as therapeutics and methods for their use
    申请人:THE UNIVERSITY OF BRITISH COLUMBIA
    公开号:US10633338B2
    公开(公告)日:2020-04-28
    This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
    本发明提供了具有以下结构式的化合物: 本发明还提供了此类化合物在治疗包括前列腺癌在内的各种适应症方面的用途,以及涉及此类化合物的治疗方法。
  • BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
    申请人:THE UNIVERSITY OF BRITISH COLUMBIA
    公开号:US20170029372A1
    公开(公告)日:2017-02-02
    This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐